Cargando…
Bacteria in Cancer Therapeutics: A Framework for Effective Therapeutic Bacterial Screening and Identification
By 2030, the global incidence of cancer is expected to increase by approximately 50%. However, most conventional therapies still lack cancer selectivity, which can have severe unintended side effects on healthy body tissue. Despite being an unconventional and contentious therapy, the last two decade...
Autores principales: | Ashu, Eta E., Xu, Jianping, Yuan, Ze-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547982/ https://www.ncbi.nlm.nih.gov/pubmed/31205534 http://dx.doi.org/10.7150/jca.31699 |
Ejemplares similares
-
Strengthening the One Health Agenda: The Role of Molecular Epidemiology in Aspergillus Threat Management
por: Ashu, Eta E., et al.
Publicado: (2018) -
Spontaneous bacterial peritonitis – therapeutic challenges in the era of increasing drug resistance of bacteria
por: Rostkowska, Karolina Anna, et al.
Publicado: (2018) -
Global Population Genetic Analysis of Aspergillus fumigatus
por: Ashu, Eta Ebasi, et al.
Publicado: (2017) -
Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada
por: Ashu, Eta E, et al.
Publicado: (2018) -
Synthetic lethality: a framework for the development of wiser cancer therapeutics
por: Kaelin, William G
Publicado: (2009)